Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer Meeting Abstract
| Authors: | Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; Fasano, J.; Gajria, D.; Drullinsky, P.; Gilewski, T.; Murphy, C.; Syldor, A.; Lau, A.; Hamilton, N.; Patil, S.; Liu, J.; Chandarlapaty, S.; Hudis, C.; Dang, C. |
| Abstract Title: | Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer |
| Meeting Title: | 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 72 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2012 Dec 4-8 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209704901226 |
| DOI: | 10.1158/0008-5472.sabcs12-p5-18-20 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P5-18-20 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work